Generics Don’t Need To Prove What Isn’t In Brand’s Label – FDA Petition Denial
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA rejects Horizon’s claims that Rayos (prednisone delayed-release) has a unique therapeutic advantage because of its delivery.